Digital Diabetes Management may Improve Glycemic Control in Diabetes patients: Study Jacinthlyn Sylvia18 March 2026 11:30 AM ISTA recent study published in the journal of Diabetes, Obesity and Metabolism has found that an online diabetes management system with digital...
Adding Fourth Oral Drug Beats Metformin Dose Escalation in Uncontrolled Type 2 Diabetes: EFFORT Trial Medha Baranwal10 March 2026 9:00 AM ISTSouth Korea: A new multicenter clinical trial published in Diabetes, Obesity & Metabolism suggests that intensifying treatment with a fourth oral...
Long term exposure to transportation noise especially from Railways May Raise Diabetes Risk, Study of Nearly 1 Million Finds Medha Baranwal18 Feb 2026 11:30 AM ISTUSA: Long-term exposure to transportation noise-especially from railways-may increase the risk of developing type 2 diabetes, a large retrospective...
Dual Metformin-GLP-1 Therapy Shows Major Reduction in Cancer Risk and Mortality: Study Dr Riya Dave12 Dec 2025 11:45 AM ISTAccording to a study published in Diabetes, Obesity and Metabolism, combining metformin with GLP-1 receptor agonists was linked to a 39% reduction in...
GLP-1 Drugs Linked to Higher Depression Risk but Lower Mortality, suggests research Dr Riya Dave17 Oct 2025 9:30 AM ISTResearchers have identified that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are widely used to control type 2 diabetes and obesity,...
Older, White Male Smokers at Higher Risk for Diabetic Foot Ulcers: Study Dr Riya Dave6 Aug 2025 8:00 AM ISTResearchers have identified that some subgroups of patients with diabetes, older males, smokers, and White ethnicity, are at significantly increased...
Weight and HbA1c Reductions Significantly Lower Death Risk in T2D, suggests study Dr Riya Dave12 July 2025 8:45 AM ISTResearchers have found in a recent study that weight loss and lowering blood sugar levels lower significantly the all-cause mortality risk in patients...
Empagliflozin Not Linked to Increased Risk of Urinary Tract Cancers: Study Dr Riya Dave26 Jun 2025 8:15 PM ISTEmpagliflozin use in patients with type 2 diabetes (T2D) has not been shown to have a higher risk of urinary tract cancers (UTCs), such as bladder and...
C-Peptide Index may Predict endogenous insulin secretory capacity under non-fasting conditions: Study Dr Riya Dave4 May 2024 10:00 AM ISTResearchers have found that the C-peptide index (CPI) at 2 hours post-meal is a significant indicator of endogenous insulin secretory capacity in...
Medical Bulletin 17/November/2023 Isra Zaman17 Nov 2023 3:00 PM ISTHere are the top medical news of the day:Weight loss within first 2 years of treating type 2 diabetes associated with remissionWeight loss within the...
Weight loss within first 2 years of treating type 2 diabetes associated with remission Isra Zaman17 Nov 2023 9:00 AM ISTResearchers used the health examination database of the Korean National Health Insurance Service. Patients diagnosed with type 2 diabetes mellitus...
GLP-1 receptor agonist therapy has CV benefits in type 2 DM, shows survival time analysis Dr. Hiral patel1 Jun 2022 9:30 AM ISTUSA: Glucagon-like peptide (GLP)-1 receptor agonists may delay the incidence of major adverse cardiovascular events (MACE) Glucagon-like peptide...
